TOVX icon

Theriva Biologics
TOVX

Overview Fund Activity

22 hedge funds and large institutions have $479K invested in Theriva Biologics in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 5 closing their positions.

Holders
22
Holders Change
-4
Holders Change %
-15.38%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
6
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VF
1
Virtu Financial
New York
$13K
2
Renaissance Technologies
2
Renaissance Technologies
New York
$15K
3
Morgan Stanley
3
Morgan Stanley
New York
$305
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$239K
5
Bank of America
5
Bank of America
North Carolina
$11

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$0
2
William Blair & Company
2
William Blair & Company
Illinois
$0
3
IA
3
IFP Advisors
Florida
$2K
4
TSS
4
Two Sigma Securities
New York
$0
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Royal Bank of Canada
26
Royal Bank of Canada
Ontario, Canada
$0 7 – –
Osaic Holdings
27
Osaic Holdings
Arizona
$0 47 – –
Rockefeller Capital Management
28
Rockefeller Capital Management
New York
$0 26 – –
1
2